Lupin gets FDA blessing for generic AravaLeflunomide tablets had a market value of roughly $44 million, according to December 2019 IQVIA data. Towa closes acquisition of Esteve's generics divisionBreckenridge is among the companies included in the acquisition. Augia Pharma gets FDA nod for generic Rheumatrex Methotrexate tablets have a market value of roughly $98 million for the 12 months ended December 2019, according to IQVIA. Global sales of branded generics are expected to grow by 8% Antihypertensives are expected to be the best-selling global branded generics category. FDA clear 2 generics from Alembic Clobetasol propionate cream and azithromycin tablets had a market value of $57 million, and $129 million respectively. Upsher-Smith launches generic Kapvay Clonidine hydrochloride ER tablets had a market value of approximately $30 million for the 12 months ended November 2019, according to IQVIA. Par launches authorized generic Carafate Sucralfate oral suspension had a market value of roughly $285 million for the 12 months ended Nov. 30, 2019, according to IQVIA. FDA approves new indication for Lundbeck’s Sabril Lundbeck's Sabril 's new indication approval closes the age gap for patients. Alembic gets FDA nod for two generics Azithromycin tablets and bosentan tablets have a market value of about $2 million, and $68 million respectively, for the 12 months ended September 2019. Pfizer to launch 3 biosimilars Pfizer is the first company to launch three oncology monoclonal antibody (mAb) biosimilar treatments. First Previous 166 167 168 169 170 Next Last
